Localized tenosynovial giant cell tumor

Changed by Henry Knipe, 19 Sep 2022
Disclosures - updated 6 Apr 2022:
  • Radiopaedia Events Pty Ltd, Speaker fees (past)
  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

Updates to Article Attributes

Title was changed:
Tenosynovial giant cell tumour of tendon sheath
Body was changed:

Tenosynovial giant cell tumours of tendon sheath are usually benign lesions that arise from the tendon sheath. It is unclearand whether these lesions represent neoplasms or merely reactive masses remains unclear. On imaging, these lesions are commonly demonstrated as localised, solitary, subcutaneous soft tissue nodules, with low T1 and T2 signal and moderate enhancement. 

Terminology

Tenosynovial giant cell tumour is the term used in the latest (2013) World Health Organisation classification 10,11. They have previously been known as giant cell tumours of the tendon sheath (GCTTS), pigmented villonodular tumour of the tendon sheath (PVNTS), extra-articular pigmented villonodular tumour of the tendon sheath, or localised or focal nodular synovitis 11.

Epidemiology 

Typically, they present in the 3rd to 5th decades and have a slight female predilection with an F:M ratio of 1.5-2.1:1 4. They are the second most common soft tissue mass of the hand and wrist.

Clinical presentation 

Clinically these masses generally present in the hand (although they are found elsewhere also) as localised swelling with or without pain. They are slow-growing. 

Pathology

Tenosynovial giant cell tumours can cause pressure erosion of adjacent bone, or rarely can invade the bone mimicking an intraosseous lesion 8.

Macroscopic appearance

Tenosynovial giant cell tumours have been divided macroscopically into localised or diffuse forms and appear as rubbery multinodular masses that are well circumscribed. They have an enveloping fibrous capsule, and the transected surface of the specimen is variably coloured depending on the relative proportions of fibrous tissue, haemosiderin, and pigmented foam cells 2.

Histology

The tumour is histologically identical to pigmented villonodular synovitis (PVNS) and is composed of fibroblasts and multinucleated giant cells, foamy histiocytes, and inflammatory cells on a background fibrous matrix 1,2.

Radiographic features

Plain radiograph

As these masses arise from tendons, commonly of the hand, they may cause pressure erosions on the underlying bone in 10-20% of cases. More commonly these masses arise from the palmar tendons. The mass itself is of soft tissue density. Periosteal reaction and calcification are uncommon 4,5.

Ultrasound

Ultrasound is useful as it allows not only the characterizationcharacterisation of the lesion but also is able to demonstrate the relationship with the adjacent tendon. On the dynamic scan, there is free movement of the tendon within the lesion. Typically they appear as:

  • associated with the volar surface of the digits
  • does not move with flexion or extension of adjacent tendons
  • usually homogeneously hypoechoic, although some heterogeneity may be seen in echotexture in a minority of cases 1
  • most will have some internal vascularity
MRI

Not surprisingly, given the histological similarity to PVNS, giant cell tumours of the tendon sheaths also share the same finding on MRI, mainly on account of hemosiderinhaemosiderin accumulation. 

Signal characteristics
  • T1: low signal
  • T2: low signal
  • T1 C+ (Gd): often show moderate enhancement 6
  • GE: low and may demonstrate blooming

Treatment and prognosis

Tenosynovial giant cell tumours are usually benign and local surgical excision usually suffices, with local recurrence (seen in 10-20% of cases) requiring more extensive surgery with or without radiotherapy being uncommon 1. Locally aggressive and malignant tenosynovial giant cell tumours can occur 11. Metastases can occur, most commonly to lymph nodes and lung 4.

Differential diagnosis

General imaging differential considerations include:

If in the hand consider:

  • -<p><strong>Tenosynovial giant cell tumours </strong>are usually benign lesions that arise from the <a href="/articles/tendon-sheath">tendon sheath</a>. It is unclear whether these lesions represent neoplasms or merely reactive masses. On imaging, these lesions are commonly demonstrated as localised, solitary, subcutaneous soft tissue nodules, with low T1 and T2 signal and moderate enhancement. </p><h4>Terminology</h4><p>Tenosynovial giant cell tumour is the term used in the latest (2013) World Health Organisation classification <sup>10,11</sup>. They have previously been known as giant cell tumours of the tendon sheath (GCTTS), pigmented villonodular tumour of the tendon sheath (PVNTS), extra-articular pigmented villonodular tumour of the tendon sheath or localised or focal nodular synovitis <sup>11</sup>.</p><h4>Epidemiology </h4><p>Typically, they present in the 3<sup>rd </sup>to 5<sup>th</sup> decades and have a slight female predilection with an F:M ratio of 1.5-2.1:1 <sup>4</sup>. They are the second most common soft tissue mass of the hand and wrist.</p><h4>Clinical presentation </h4><p>Clinically these masses generally present in the hand (although they are found elsewhere also) as localised swelling with or without pain. They are slow-growing. </p><h4>Pathology</h4><p>Tenosynovial giant cell tumours can cause pressure erosion of adjacent bone, or rarely can invade the bone mimicking an intraosseous lesion <sup>8</sup>.</p><h5>Macroscopic appearance</h5><p>Tenosynovial giant cell tumours have been divided macroscopically into localised or diffuse forms and appear as rubbery multinodular masses that are well circumscribed. They have an enveloping fibrous capsule, and the transected surface of the specimen is variably coloured depending on the relative proportions of fibrous tissue, haemosiderin, and pigmented foam cells <sup>2</sup>.</p><h5>Histology</h5><p>The tumour is histologically identical to <a href="/articles/pigmented-villonodular-synovitis">pigmented villonodular synovitis (PVNS)</a> and is composed of fibroblasts and multinucleated giant cells, foamy histiocytes, and inflammatory cells on a background fibrous matrix <sup>1,2</sup>.</p><h4>Radiographic features</h4><h5>Plain radiograph</h5><p>As these masses arise from tendons, commonly of the hand, they may cause pressure erosions on the underlying bone in 10-20% of cases. More commonly these masses arise from the palmar tendons. The mass itself is of soft tissue density. Periosteal reaction and calcification are uncommon <sup>4,5</sup>.</p><h5>Ultrasound</h5><p>Ultrasound is useful as it allows not only the characterization of the lesion but also is able to demonstrate the relationship with the adjacent tendon. On the dynamic scan, there is free movement of the tendon within the lesion. Typically they appear as:</p><ul>
  • +<p><strong>Tenosynovial giant cell tumours of tendon sheath </strong>are usually benign lesions and whether these lesions represent neoplasms or reactive masses remains unclear. On imaging, these lesions are commonly demonstrated as localised, solitary, subcutaneous soft tissue nodules, with low T1 and T2 signal and moderate enhancement. </p><h4>Terminology</h4><p>Tenosynovial giant cell tumour is the term used in the latest (2013) World Health Organisation classification <sup>10,11</sup>. They have previously been known as giant cell tumours of the tendon sheath (GCTTS), pigmented villonodular tumour of the tendon sheath (PVNTS), extra-articular pigmented villonodular tumour of the tendon sheath, or localised or focal nodular synovitis <sup>11</sup>.</p><h4>Epidemiology </h4><p>Typically, they present in the 3<sup>rd </sup>to 5<sup>th</sup> decades and have a slight female predilection with an F:M ratio of 1.5-2.1:1 <sup>4</sup>. They are the second most common soft tissue mass of the hand and wrist.</p><h4>Clinical presentation </h4><p>Clinically these masses generally present in the hand (although they are found elsewhere also) as localised swelling with or without pain. They are slow-growing. </p><h4>Pathology</h4><p>Tenosynovial giant cell tumours can cause pressure erosion of adjacent bone, or rarely can invade the bone mimicking an intraosseous lesion <sup>8</sup>.</p><h5>Macroscopic appearance</h5><p>Tenosynovial giant cell tumours have been divided macroscopically into localised or diffuse forms and appear as rubbery multinodular masses that are well circumscribed. They have an enveloping fibrous capsule, and the transected surface of the specimen is variably coloured depending on the relative proportions of fibrous tissue, haemosiderin, and pigmented foam cells <sup>2</sup>.</p><h5>Histology</h5><p>The tumour is histologically identical to <a href="/articles/pigmented-villonodular-synovitis">pigmented villonodular synovitis (PVNS)</a> and is composed of fibroblasts and multinucleated giant cells, foamy histiocytes, and inflammatory cells on a background fibrous matrix <sup>1,2</sup>.</p><h4>Radiographic features</h4><h5>Plain radiograph</h5><p>As these masses arise from tendons, commonly of the hand, they may cause pressure erosions on the underlying bone in 10-20% of cases. More commonly these masses arise from the palmar tendons. The mass itself is of soft tissue density. Periosteal reaction and calcification are uncommon <sup>4,5</sup>.</p><h5>Ultrasound</h5><p>Ultrasound is useful as it allows not only the characterisation of the lesion but also is able to demonstrate the relationship with the adjacent tendon. On the dynamic scan, there is free movement of the tendon within the lesion. Typically they appear as:</p><ul>
  • -</ul><h5>MRI</h5><p>Not surprisingly, given the histological similarity to PVNS, giant cell tumours of the tendon sheaths also share the same finding on MRI, mainly on account of hemosiderin accumulation. </p><h6>Signal characteristics</h6><ul>
  • +</ul><h5>MRI</h5><p>Not surprisingly, given the histological similarity to PVNS, giant cell tumours of the tendon sheaths also share the same finding on MRI, mainly on account of haemosiderin accumulation. </p><h6>Signal characteristics</h6><ul>
Images Changes:

Image 3 Photo ( update )

Position was set to .

Image 4 MRI (T1) ( update )

Position was set to .

Image 5 MRI (T1) ( update )

Position was set to .

Image 6 MRI (T2) ( update )

Position was set to .

Image 7 Ultrasound ( update )

Position was set to .

Image 8 X-ray (Lateral) ( update )

Position was set to .

Image 9 MRI (T1) ( update )

Position was set to .

Image 10 MRI (T1) ( update )

Position was set to .

Image 11 MRI (T2) ( update )

Position was set to .

Image 12 MRI (T1) ( update )

Position was set to .

Image 13 Annotated image ( update )

Position was set to .

Image 14 MRI (T2) ( update )

Position was set to .

Image 15 MRI (PD fat sat) ( update )

Position was set to .

Image 16 MRI (T1) ( update )

Position was set to .

Image 18 MRI (T1) ( update )

Position was set to .

Image 22 Ultrasound (multiple planes) ( update )

Position was set to .

Updates to Link Attributes

Title was removed:
Tenosynovial giant cell tumour
Type was removed.
Visible was set to .

Updates to Link Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.